Silence Therapeutics (SLN) Shares Outstanding (Diluted) (2022 - 2026)
Silence Therapeutics (SLN) posted Shares Outstanding (Diluted) of 47.24 million for the quarter ended Jun 30, 2026, unchanged from 47.23 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Silence Therapeutics (SLN) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Silence Therapeutics' Shares Outstanding (Diluted) came in at 47.23 million, up 2.1% from the prior year.
- Annual Shares Outstanding (Diluted) has increased for three consecutive years, with a three-year compound annual growth rate of 13.6% (years ended Dec 2022 to Dec 2025).
- In prior years, Silence Therapeutics' Shares Outstanding (Diluted) was 46.25 million in the year ended Dec 31, 2024 (+24.7%), 37.09 million in the year ended Dec 31, 2023 (+15.2%) and 32.19 million in the year ended Dec 31, 2022.
- The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly Shares Outstanding (Diluted) in data going back to the quarter ended Dec 31, 2022.
- On a year-over-year basis, Shares Outstanding (Diluted) increased in five of the last seven quarters, with growth averaging 5.1%.
- Over the past five years, the year-over-year growth in Shares Outstanding (Diluted) ranged from 0.0% (the quarter ended Jun 30, 2026) to 24.7% (the quarter ended Dec 31, 2024).
- According to Business Quant data, Shares Outstanding (Diluted) for the three prior quarters was 47.23 million (quarter ended Mar 31, 2026), 47.23 million (quarter ended Dec 31, 2025) and 47.23 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Silence Therapeutics | 516.41 Mn | 444.31 Mn | - | 47.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.24 Mn |
| Mar 31, 2026 | 47.23 Mn |
| Dec 31, 2025 | 47.23 Mn |
| Sep 30, 2025 | 47.23 Mn |
| Jun 30, 2025 | 47.23 Mn |
| Mar 31, 2025 | 47.23 Mn |
| Dec 31, 2024 | 46.25 Mn |
| Sep 30, 2024 | 47.07 Mn |
| Jun 30, 2024 | 46.74 Mn |
| Mar 31, 2024 | 43.96 Mn |
| Dec 31, 2023 | 37.09 Mn |
| Dec 31, 2022 | 32.19 Mn |
API Access
Silence Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=SLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "SLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=SLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();